Category Archives: The Lancet

  1. Policy Implications of The Lancet MSM & HIV Series

    via Center for Strategic & International Studies In light of the need to address key populations in the HIV epidemic, the Center for Strategic and International Studies is convening several authors to discuss a special issue of The Lancet focused on the global HIV epidemic among men who have sex with men (MSM). Thursday, September 6th3:00pm—5:00pm (EST)B1 Conference Read More >>

    HIV, HIV transmission, HIV/AIDS, MSM, The Lancet
  2. The Pope, Condoms and the Evolution of HIV

    [Enjoy the additional Pope/condom images as light Friday entertainment from IRMA…] From The Lancet Infectious Diseases, Volume 9, Issue 8, Pages 461 – 462, August 2009. Samuel Ponce de Leon, et al. The unjustifiable nature of the Vatican’s opposition to condoms in the face of the spread of HIV has been underlined by many.1 Moreover, the claims Read More >>

    condoms, Pope, resistance, The Lancet
  3. Rates of HIV among MSM in Africa: A Review

    IRMA is thrilled to see an increase in attention to this issue in the past two years. The Lancet has just published a review of studies that could provide information on HIV prevalence rates among MSM in Africa. The summary and link to the full article can be found below, as is a glimpse at a BBC Read More >>

    Africa, gay men, MSM, prevalence, The Lancet
  4. The Lancet publishes results from Uganda trial: Showed that circumcising HIV+ men did not protect women

    “Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial.” Maria J Wawer, Frederick Makumbi, Godfrey Kigozi, David Serwadda, Stephen Watya, Fred Nalugoda, Dennis Buwembo, Victor Ssempijja, Noah Kiwanuka, Lawrence H Moulton, Nelson K Sewankambo, Steven J Reynolds, Thomas C Quinn, Pius Opendi, Boaz Iga, Renee Ridzon, Read More >>

    circumcision, HIV transmission, research, The Lancet, Uganda, women
  5. The Lancet To Publish Carraguard Phase 3 Trial Results

    via the Population Council Trial Showed Anti-HIV Microbicide Candidate Is Safe, but Did Not Prove It Effective The Lancet will publish the results of the Phase 3 clinical trial of the microbicide candidate Carraguard® in its 6 December issue (available online on Friday 5 December). The Population Council sponsored the study at three sites in South Africa Read More >>

    Carraguard, research, The Lancet, vaginal microbicide